8-K//Current report
ABVC BIOPHARMA, INC. 8-K
Accession 0001213900-25-051144
$ABVCCIK 0001173313operating
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:01 PM ET
Size
207.7 KB
Accession
0001213900-25-051144
Documents
- 8-Kea024460401-8k_abvcbio.htmPrimary
CURRENT REPORT
- EX-101.SCHabvc-20250603.xsd
XBRL SCHEMA FILE
- EX-101.LABabvc-20250603_lab.xml
XBRL LABEL FILE
- EX-101.PREabvc-20250603_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-051144-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea024460401-8k_abvcbio_htm.xml
IDEA: XBRL DOCUMENT
Issuer
ABVC BIOPHARMA, INC.
CIK 0001173313
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001173313
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:01 PM ET
- Size
- 207.7 KB